Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 145
Filtrar
Más filtros

Intervalo de año de publicación
1.
Heliyon ; 10(18): e37599, 2024 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-39315190

RESUMEN

In this work, we report the investigation of the effect of exposure of apple trees to the bioeffector wood distillate (WD), a plant biostimulant used for improving the nutritional profiling of crop plants. We measured the effect by evaluating the biochemical and nutritional profile of both pulps and skin of fruits. WD (0.2 %, v/v) was applied once a week by foliar application, from May 2023 until September 2023. The results indicate that the WD-treated apples have a significant increase in several analyzed parameters (i.e., phenols, flavonoids, tannins, total antioxidant power, sugars, pectin, free amino acids, and mineral element content), especially in the pulp. These data were also confirmed by NMR and LC-ESI-MS techniques. This study pointed out that WD could be a handy tool for the cultivation of fruit trees.

2.
ACS Pharmacol Transl Sci ; 7(7): 2125-2142, 2024 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-39022363

RESUMEN

Blood cancers encompass a group of diseases affecting the blood, bone marrow, or lymphatic system, representing the fourth most commonly diagnosed cancer worldwide. Leukemias are characterized by the dysregulated proliferation of myeloid and lymphoid cells with different rates of progression (acute or chronic). Among the chronic forms, hairy cell leukemia (HCL) is a rare disease, and no drugs have been approved to date. However, acute myeloid leukemia (AML) is one of the most aggressive malignancies, with a low survival rate, especially in cases with FLT3-ITD mutations. Epigenetic modifications have emerged as promising strategies for the treatment of blood cancers. Epigenetic modulators, such as histone deacetylase (HDAC) inhibitors, are increasingly used for targeted cancer therapy. New hydroxamic acid derivatives, preferentially inhibiting HDAC6 (5a-q), were developed and their efficacy was investigated in different blood cancers, including multiple myeloma (MM), HCL, and AML, pointing out their pro-apoptotic effect as the mechanism of cell death. Among the inhibitors described, 5c, 5g, and 5h were able to rescue the hematopoietic phenotype in vivo using the FLT3-ITD zebrafish model of AML. 5c (leuxinostat) proved its efficacy in cells from FLT3-ITD AML patients, promoting marked acetylation of α-tubulin compared to histone H3, thereby confirming HDAC6 as a preferential target for this new class of hydroxamic acid derivatives at the tested doses.

3.
J Med Chem ; 67(17): 14946-14973, 2024 Sep 12.
Artículo en Inglés | MEDLINE | ID: mdl-38961727

RESUMEN

Inherited retinal diseases, which include retinitis pigmentosa, are a family of genetic disorders characterized by gradual rod-cone degeneration and vision loss, without effective pharmacological treatments. Experimental approaches aim to delay disease progression, supporting cones' survival, crucial for human vision. Histone deacetylases (HDACs) mediate the activation of epigenetic and nonepigenetic pathways that modulate cone degeneration in RP mouse models. We developed new HDAC inhibitors (5a-p), typified by a tetrahydro-γ-carboline scaffold, characterized by high HDAC6 inhibition potency with balanced physicochemical properties for in vivo studies. Compound 5d (repistat, IC50 HDAC6 = 6.32 nM) increased the levels of acetylated α-tubulin compared to histone H3 in ARPE-19 and 661W cells. 5d promoted vision rescue in the atp6v0e1-/- zebrafish model of photoreceptor dysfunction. A single intravitreal injection of 5d in the rd10 mouse model of RP supported morphological and functional preservation of cone cells and maintenance of the retinal pigment epithelium array.


Asunto(s)
Inhibidores de Histona Desacetilasas , Células Fotorreceptoras Retinianas Conos , Pez Cebra , Animales , Células Fotorreceptoras Retinianas Conos/metabolismo , Células Fotorreceptoras Retinianas Conos/efectos de los fármacos , Células Fotorreceptoras Retinianas Conos/patología , Humanos , Ratones , Inhibidores de Histona Desacetilasas/farmacología , Inhibidores de Histona Desacetilasas/química , Inhibidores de Histona Desacetilasas/uso terapéutico , Retinitis Pigmentosa/metabolismo , Retinitis Pigmentosa/tratamiento farmacológico , Retinitis Pigmentosa/patología , Histona Desacetilasas/metabolismo , Histona Desacetilasa 6/antagonistas & inhibidores , Histona Desacetilasa 6/metabolismo , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Relación Estructura-Actividad
4.
Biomed Pharmacother ; 174: 116537, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38579402

RESUMEN

Chronic Lymphocytic Leukemia (CLL) patients have a defective expression of the proapoptotic protein p66Shc and of its transcriptional factor STAT4, which evoke molecular abnormalities, impairing apoptosis and worsening disease prognosis and severity. p66Shc expression is epigenetically controlled and transcriptionally modulated by STAT4; epigenetic modifiers are deregulated in CLL cells and specific histone deacetylases (HDACs) like HDAC1, are overexpressed. Reactivation of STAT4/p66Shc expression may represent an attractive and challenging strategy to reverse CLL apoptosis defects. New selective class I HDAC inhibitors (HDACis, 6a-g) were developed with increased potency over existing agents and preferentially interfering with the CLL-relevant isoform HDAC1, to unveil the role of class I HDACs in the upregulation of STAT4 expression, which upregulates p66Shc expression and hence normalizes CLL cell apoptosis. 6c (chlopynostat) was identified as a potent HDAC1i with a superior profile over entinostat. 6c induces marked apoptosis of CLL cells compared with SAHA, which was associated with an upregulation of STAT4/p66Shc protein expression. The role of HDAC1, but not HDAC3, in the epigenetic upregulation of STAT4/p66Shc was demonstrated for the first time in CLL cells and was validated in siRNA-induced HDAC1/HDAC3 knock-down EBV-B cells. To sum up, HDAC1 inhibition is necessary to reactivate STAT4/p66Shc expression in patients with CLL. 6c is one of the most potent HDAC1is known to date and represents a novel pharmacological tool for reversing the impairment of the STAT4/p66Shc apoptotic machinery.


Asunto(s)
Apoptosis , Linfocitos B , Inhibidores de Histona Desacetilasas , Leucemia Linfocítica Crónica de Células B , Factor de Transcripción STAT4 , Proteína Transformadora 1 que Contiene Dominios de Homología 2 de Src , Humanos , Leucemia Linfocítica Crónica de Células B/tratamiento farmacológico , Leucemia Linfocítica Crónica de Células B/patología , Leucemia Linfocítica Crónica de Células B/metabolismo , Apoptosis/efectos de los fármacos , Inhibidores de Histona Desacetilasas/farmacología , Proteína Transformadora 1 que Contiene Dominios de Homología 2 de Src/metabolismo , Proteína Transformadora 1 que Contiene Dominios de Homología 2 de Src/genética , Factor de Transcripción STAT4/metabolismo , Linfocitos B/efectos de los fármacos , Linfocitos B/metabolismo , Histona Desacetilasa 1/metabolismo , Histona Desacetilasa 1/antagonistas & inhibidores , Benzamidas/farmacología , Masculino , Anciano , Femenino , Persona de Mediana Edad
5.
ACS Infect Dis ; 10(5): 1520-1535, 2024 05 10.
Artículo en Inglés | MEDLINE | ID: mdl-38669567

RESUMEN

The term "zoonosis" denotes diseases transmissible among vertebrate animals and humans. These diseases constitute a significant public health challenge, comprising 61% of human pathogens and causing an estimated 2.7 million deaths annually. Zoonoses not only affect human health but also impact animal welfare and economic stability, particularly in low- and middle-income nations. Leishmaniasis and schistosomiasis are two important neglected tropical diseases with a high prevalence in tropical and subtropical areas, imposing significant burdens on affected regions. Schistosomiasis, particularly rampant in sub-Saharan Africa, lacks alternative treatments to praziquantel, prompting concerns regarding parasite resistance. Similarly, leishmaniasis poses challenges with unsatisfactory treatments, urging the development of novel therapeutic strategies. Effective prevention demands a One Health approach, integrating diverse disciplines to enhance diagnostics and develop safer drugs. Metalloenzymes, involved in parasite biology and critical in different biological pathways, emerged in the last few years as useful drug targets for the treatment of human diseases. Herein we have reviewed recent reports on the discovery of inhibitors of metalloenzymes associated with zoonotic diseases like histone deacetylases (HDACs), carbonic anhydrase (CA), arginase, and heme-dependent enzymes.


Asunto(s)
Leishmania , Leishmaniasis , Schistosoma , Esquistosomiasis , Zoonosis , Animales , Humanos , Leishmaniasis/tratamiento farmacológico , Leishmaniasis/parasitología , Schistosoma/efectos de los fármacos , Schistosoma/enzimología , Zoonosis/tratamiento farmacológico , Esquistosomiasis/tratamiento farmacológico , Leishmania/efectos de los fármacos , Leishmania/enzimología , Anhidrasas Carbónicas/metabolismo , Histona Desacetilasas/metabolismo , Inhibidores Enzimáticos/farmacología
6.
Food Chem ; 444: 138684, 2024 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-38359701

RESUMEN

A research platform for food authentication was set up by combining stable isotope ratio analysis, metabolomics by gas and liquid mass-spectrometry and NMR investigations, chemometric analyses for food excellences. This multi-analytical approach was tested on samples of elephant garlic (Allium ampeloprasum L.), a species belonging to the same genus of common garlic (Allium ampeloprasum L.), mainly produced in southern Tuscany-(Allium ampeloprasum). The isotopic composition allowed the product to be geographically characterized. Flavonoids, like (+)-catechin, cinnamic acids, quercetin glycosides were identified. The samples showed also a significant amount of dipeptides, sulphur-containing metabolites and glutathione, the latter of which could be considered a molecular marker of the analyzed elephant garlic. For nutraceutical profiling to reach quality labels, extracts were investigated in specific biological assays, displaying interesting vasorelaxant properties in rat aorta by mediating nitric oxide release from the endothelium and exhibited positive inotropic and negative chronotropic effects in rat perfused heart.


Asunto(s)
Allium , Ajo , Animales , Ratas , Ajo/química , Allium/química , Cebollas/química , Antioxidantes/análisis , Suplementos Dietéticos , Italia
7.
PLoS Negl Trop Dis ; 18(2): e0011992, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38416775

RESUMEN

Schistosomiasis is a major neglected parasitic disease that affects more than 240 million people worldwide caused by Platyhelminthes of the genus Schistosoma. The treatment of schistosomiasis relies on the long-term application of a single safe drug, praziquantel (PZQ). Unfortunately, PZQ is very effective on adult parasites and poorly on larval stage and immature juvenile worms; this can partially explain the re-infection in endemic areas where patients are likely to host parasites at different developmental stages concurrently. Moreover, the risk of development of drug resistance because of the widespread use of a single drug in a large population is nowadays a serious threat. Hence, research aimed at identifying novel drugs to be used alone or in combination with PZQ is needed. Schistosomes display morphologically distinct stages during their life cycle and epigenetic mechanisms are known to play important roles in parasite growth, survival, and development. Histone deacetylase (HDAC) enzymes, particularly HDAC8, are considered valuable for therapeutic intervention for the treatment of schistosomiasis. Herein, we report the phenotypic screening on both larvae and adult Schistosoma mansoni stages of structurally different HDAC inhibitors selected from the in-house Siena library. All molecules have previously shown inhibition profiles on human HDAC6 and/or HDAC8 enzymes. Among them we identified a quinolone-based HDAC inhibitor, NF2839, that impacts larval and adult parasites as well as egg viability and maturation in vitro. Importantly, this quinolone-based compound also increases histone and tubulin acetylation in S. mansoni parasites, thus representing a leading candidate for the development of new generation anti-Schistosoma chemotherapeutics.


Asunto(s)
Antihelmínticos , Inhibidores de Histona Desacetilasas , Quinolonas , Esquistosomiasis mansoni , Esquistosomiasis , Animales , Humanos , Antihelmínticos/farmacología , Antihelmínticos/uso terapéutico , Histona Desacetilasa 6/antagonistas & inhibidores , Larva , Praziquantel/farmacología , Praziquantel/uso terapéutico , Quinolonas/farmacología , Proteínas Represoras , Schistosoma mansoni , Esquistosomiasis/tratamiento farmacológico , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/parasitología , Inhibidores de Histona Desacetilasas/química , Inhibidores de Histona Desacetilasas/farmacología , Inhibidores de Histona Desacetilasas/uso terapéutico
8.
J Med Chem ; 67(3): 1758-1782, 2024 02 08.
Artículo en Inglés | MEDLINE | ID: mdl-38241614

RESUMEN

New potent, selective monoacylglycerol lipase (MAGL) inhibitors based on the azetidin-2-one scaffold ((±)-5a-v, (±)-6a-j, and (±)-7a-d) were developed as irreversible ligands, as demonstrated by enzymatic and crystallographic studies for (±)-5d, (±)-5l, and (±)-5r. X-ray analyses combined with extensive computational studies allowed us to clarify the binding mode of the compounds. 5v was identified as selective for MAGL when compared with other serine hydrolases. Solubility, in vitro metabolic stability, cytotoxicity, and absence of mutagenicity were determined for selected analogues. The most promising compounds ((±)-5c, (±)-5d, and (±)-5v) were used for in vivo studies in mice, showing a decrease in MAGL activity and increased 2-arachidonoyl-sn-glycerol levels in forebrain tissue. In particular, 5v is characterized by a high eudysmic ratio and (3R,4S)-5v is one of the most potent irreversible inhibitors of h/mMAGL identified thus far. These results suggest that the new MAGL inhibitors have therapeutic potential for different central and peripheral pathologies.


Asunto(s)
Inhibidores Enzimáticos , Monoacilglicerol Lipasas , Ratones , Animales , Inhibidores Enzimáticos/farmacología , Inhibidores Enzimáticos/química , Monoglicéridos , Ligandos
9.
Chem Biol Drug Des ; 103(1): e14415, 2024 01.
Artículo en Inglés | MEDLINE | ID: mdl-38230797

RESUMEN

Cinnamic acid and its derivatives represent attractive building blocks for the development of pharmacological tools. A series of piperoniloyl and cinnamoyl-based amides (6-9 a-f) have been synthesized and assayed against a wide panel of colorectal cancer (CRC) cells, with the aim of finding promising anticancer agents. Among all twenty-four synthesized molecules, 7a, 7e-f, 9c, and 9f displayed the best antiproliferative activity. The induced G1 cell cycle arrest and the increase in apoptotic cell death was seen in FACS analysis and western Blotting in the colon tumor cell lines HCT116, SW480, LoVo, and HT29, but not in the nontumor cell line HCEC. In particular, 9f overcame the resistance of HT29 cells, which have a mutant p53 and BRAF. Furthermore, 9f, amide of piperonilic acid with the 3,4-dichlorobenzyl substituent upregulated p21, which is involved in cell cycle arrest as well as in apoptosis induction. Cinnamic acid derivatives might be potential anticancer compounds, useful for the development of promising anti-CRC agents.


Asunto(s)
Antineoplásicos , Neoplasias Colorrectales , Humanos , Proliferación Celular , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Cinamatos/farmacología , Línea Celular Tumoral , Apoptosis , Neoplasias Colorrectales/tratamiento farmacológico
10.
Artículo en Portugués | LILACS, INDEXPSI | ID: biblio-1567501

RESUMEN

Este artigo tem como objetivo analisar aspectos do trabalho real no setor elétrico, os quais distanciam e aproximam os operadores de um meio ambiente de trabalho equilibrado. A pesquisa foi realizada com oito Eletricistas de Linha Viva (ELV), que atuavam em uma companhia elétrica do setor privado em processo de distribuição de energia executando tarefa de Poda de Vegetação. A pesquisa baseou-se na aplicação da Análise Ergonômica do Trabalho (AET) para compreensão do trabalho real, articulada às contribuições teóricas do campo do direito acerca do conceito de "meio ambiente de trabalho equilibrado". Como resultado, identificaram-se condições que podem gerar fadiga física e riscos aos trabalhadores, assim como questões relacionadas à organização do trabalho e demandas cognitivas com implicações para a segurança, que podem distanciar os operadores de um meio ambiente de trabalho equilibrado. Também foram identificados aspectos de satisfação no trabalho, que favorecem a constituição da identidade revelada por meio do desenvolvimento do ofício e pelo senso de pertencimento e cooperação no trabalho desempenhado em equipe, situações que aproximam os trabalhadores de um meio ambiente de trabalho equilibrado


This article analyzes real work aspects in the electricity sector, which distance and bring electricians closer to a balanced work environment. Research was conducted with eight live-front electricians from a private electric company who worked in energy distribution processes performing vegetation pruning. Ergonomic Work Analysis (EWA) helped to understand real work, articulated to theoretical contributions from Law about the concept of "balanced work environment". Analysis identified conditions that can generate physical fatigue and occupational risks, as well as issues related to work organization and cognitive demands which can affect safety and distance operators from a balanced work environment. The aspects of job satisfaction identified favor constituting the identity revealed by the development of the craft and the sense of belonging and work cooperation, situations that bring workers closer to a balanced work environment


Asunto(s)
Humanos , Masculino , Riesgos Laborales , Personal de Operación , Electricidad , Contaminación Electromagnética , Condiciones de Trabajo , Ergonomía , Sector Privado , Satisfacción en el Trabajo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA